Pfizer beats profit estimates on cost cuts, COVID vaccine sales
(Reuters) -Drugmaker Pfizer posted a better than expected fourth quarter profit on Thursday, helped by cost cuts and a ...
STAT8d
Pharmalittle: We’re reading about tariffs’ effect on drug costs, a scrapped vaccine plant expansion, and more
This would reverse progress toward curbing drug shortages. AstraZeneca scrapped plans to invest $558.3 million in its vaccine ...
Yahoo Finance7d
Pfizer shows profit growth from cost cuts and steadier COVID sales
and another $1.5 billion by simplifying its manufacturing operations by 2027. Its cost of sales fell 22% in the quarter to $5.9 billion from $7.6 billion a year ago. Revenue from COVID vaccine ...
Benzinga.com8d
STAT+: Pharmalittle: We're reading about tariffs' effect on drug costs, a scrapped vaccine plant expansion, and more
On Saturday, President Trump ordered import taxes on goods from Canada, China, and Mexico, a move that could raise costs for consumers ... $558.3 million in its vaccine manufacturing plant in ...
RTE Online7d
Pfizer beats profit estimates on cost cuts, Covid vaccine sales
Drugmaker Pfizer has today posted a better than expected fourth quarter profit, helped by cost cuts and a smaller-than-feared drop in sales of its Covid-19 vaccine. "Our revenue volatility is ...